Structure Therapeutics Newsroom

Analysts Offer Insights on Healthcare Companies: Artelo Biosciences (ARTL) and Structure Therapeutics, Inc. Sponsored ADR (GPCR)

TipRanksDec 9 23:32

Structure Therapeutics Analyst Ratings

BenzingaDec 4 19:31

Morgan Stanley Maintains Structure Therapeutics(GPCR.US) With Buy Rating, Maintains Target Price $118

Futu NewsNov 15 21:31

Jefferies Maintains Structure Therapeutics(GPCR.US) With Buy Rating, Maintains Target Price $79

Futu NewsNov 14 21:35

BMO Capital Maintains Structure Therapeutics(GPCR.US) With Buy Rating, Maintains Target Price $100

Futu NewsNov 14 20:33

Piper Sandler Maintains Structure Therapeutics(GPCR.US) With Buy Rating, Maintains Target Price $93

Futu NewsNov 14 20:31

Piper Sandler Maintains Structure Therapeutics(GPCR.US) With Buy Rating, Maintains Target Price $93

Futu NewsNov 5 20:37

Piper Sandler Remains a Buy on Structure Therapeutics, Inc. Sponsored ADR (GPCR)

TipRanksNov 5 20:00

BMO Capital Maintains Structure Therapeutics(GPCR.US) With Buy Rating, Maintains Target Price $100

Futu NewsOct 21 20:31

Cantor Fitzgerald Maintains Structure Therapeutics(GPCR.US) With Buy Rating, Maintains Target Price $65

Futu NewsSep 23 20:33

Structure Therapeutics Price Target Announced at $118.00/Share by Morgan Stanley

Dow JonesSep 23 20:18

Cantor Fitzgerald Sticks to Their Buy Rating for Structure Therapeutics, Inc. Sponsored ADR (GPCR)

TipRanksSep 23 19:59

Morgan Stanley Initiates Structure Therapeutics(GPCR.US) With Buy Rating, Announces Target Price $118

Futu NewsSep 23 17:33

Structure Therapeutics Analyst Ratings

BenzingaSep 16 23:50

Cantor Fitzgerald Reiterates Overweight on Structure Therapeutics, Maintains $65 Price Target

BenzingaSep 16 23:50

JMP Securities Maintains Structure Therapeutics(GPCR.US) With Buy Rating, Maintains Target Price $86

Futu NewsSep 11 01:32

Buy Rating on Structure Therapeutics: Promising GSBR-1290 Clinical Developments and Competitive Market Positioning

TipRanksSep 11 00:38

Jefferies Maintains Structure Therapeutics(GPCR.US) With Buy Rating, Maintains Target Price $79

Futu NewsSep 10 20:31

Piper Sandler Maintains Structure Therapeutics(GPCR.US) With Buy Rating, Maintains Target Price $93

Futu NewsSep 10 19:33

Structure Therapeutics, Inc. Sponsored ADR (GPCR) Receives a Buy From Piper Sandler

TipRanksSep 10 18:41